Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Juan Francisco Gonzalez Guerrero"'
Autor:
Jose F. Muñoz Lozano, Diana Cristina Pérez Ibave, Estefania Abundis Marquez, Fernando Alcorta Nuñez, Celia B. Gonzalez Alcorta, Carlos Salazar Mejia, Maria Fernanda Noriega, Omar Zayas Villanueva, Victor Oyervides Juarez, Larisa M. Renteria Garcia, Adelina Alcorta Garza, Juan Francisco Gonzalez Guerrero, Valeria Luna, David Hernandez, Rafael Piñeiro Retif, Oscar Vidal Gutiérrez
Publikováno v:
Cancer Research. 83:P1-08
INTRODUCTION Radiotherapy is an area of medicine that is little known by patients and that requires a long time for the doctor to be able to explain and resolve the doubts that arise in the first consultation, which may cause anxiety and low adherenc
Autor:
Sandra K. Santuario-Facio, Servando Cardona-Huerta, Yadira X. Perez-Paramo, Victor Trevino, Francisco Hernandez-Cabrera, Augusto Rojas-Martinez, Grecia Uscanga-Perales, Jorge L. Martinez-Rodriguez, Lizeth Martinez-Jacobo, Gerardo Padilla-Rivas, Gerardo Muñoz-Maldonado, Juan Francisco Gonzalez-Guerrero, Javier Valero-Gomez, Ana L. Vazquez-Guerrero, Herminia G. Martinez-Rodriguez, Alvaro Barboza-Quintana, Oralia Barboza-Quintana, Raquel Garza-Guajardo, Rocio Ortiz-Lopez
Publikováno v:
Molecular Medicine, Vol 23, Iss 1, Pp 101-111 (2017)
Abstract Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer tumors. Comparisons between TNBC and non-triple-negative breast cancer (nTNBC) may help to differentiate key components involved in TNBC neoplasms. The purpose of
Externí odkaz:
https://doaj.org/article/feac25982a1f4bdfa4a90e8b2dcaf196
Autor:
Blanca Angélica Soto-Martínez, Adelina Alcorta-Garza, Fernando Alcorta-Núñez, Guillermo Alberto Porras, Juan Francisco Gonzalez-Guerrero, Alan Reyes-Mondragon, Daniela Ramos-Guzman, Oscar Vidal-Gutierrez
Publikováno v:
Quality of life after treatment.
Autor:
Jose F. Muñoz Lozano, Omar Zayas Villanueva, Estefania Abundis Marquez, Fernando Alcorta Nuñez, Maria Fernanda Noriega, Carlos Salazar Mejia, Celia B. Gonzalez Alcorta, Diana Cristina Pérez Ibave, Victor Oyervides Juarez, Larisa M. Renteria Garcia, Adelina Alcorta Garza, Juan Francisco Gonzalez Guerrero, David Hernandez, Rafael Piñeiro Retif, Oscar Vidal Gutiérrez
Publikováno v:
Cancer Research. 83:P5-04
Introduction A minority of women with breast cancer in Mexico are diagnosed through a screening program with a low rate of national coverage of about 20%, which translates into late diagnosis and worse outcomes. The detection of high-risk groups thro
Autor:
José Carlos Cessa-Zanatta, Fernando Alcorta-Nuñez, Adelina Alcorta-Garza, Juan Manuel Muñoz-Ayala, Oscar Vidal-Gutiérrez, Juan Francisco Gonzalez Guerrero, David Hernández-Barajas
Publikováno v:
Journal of Clinical Oncology. 38:e16515-e16515
e16515 Background: Esophageal cancer is a highly lethal entity. Within this group of tumors, squamous cell carcinoma (SCC) and esophageal adenocarcinoma (ACE) represent 95% of the total. For most of the twentieth century, the SCC predominated through
Autor:
Celia Beatriz Gonzalez-Alcorta, Adelina Alcorta-Garza, Juan Francisco Gonzalez Guerrero, Fernando Alcorta-Nuñez, Oscar Vidal-Gutiérrez, Jan Alejandro Montiel-Labastida, María Lourdes Garza-Rodríguez, Antonia Gloria Alcorta-Garza
Publikováno v:
Journal of Clinical Oncology. 38:e24113-e24113
e24113 Background: Chronic cancer pain generates fear and anguish in cancer patients. It is suffered by 64% of patients with metastatic or terminal disease, 59% of patients in early and intermediate stages, and 33% of patients cured from cancer. They
Autor:
Jose Luis Gonzalez Vela, Lorena Itzel González-Palau, Carlos Eduardo Salazar-Mejía, Blanca Otilia Wimer-Castillo, Diego A Jaime-Villalon, Oscar Vidal-Gutiérrez, Francisco Emilio Vera Badillo, Jackeline Grace Lara-Campos, Juan Francisco Gonzalez Guerrero, Luis Antonio Cancel
Publikováno v:
Journal of Clinical Oncology. 37:6569-6569
6569 Background: Breast cancer (BC) is one of the leading issues in public health in low and middle-income countries. In Mexico, access to healthcare is fragmented according to the patient´s employment and not by its needs; IMSS and ISSTE (Social Se
Autor:
Clara, Patricia Rios-Ibarra, Claudia, Janeth Rodriguez-Silva, Yamil, Alonso Lopez-Chuken, Rocio, Ortiz-Lopez, Elisa, Fernandez-Castillo, Claudia, Beatriz Del Toro Runzer, Vicente, Paul Armenta-Perez, Juan Pablo, Flores-Gutierrez, Arturo, Quintanilla-Guzman, Mauricio, Salinas-Santander, Juan Francisco, Gonzalez-Guerrero, Francisco, Bosques-Padilla, Arturo, Santos, Herminia, Guadalupe Martinez-Rodriguez
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 21(4)
We analyzed the genotype and allele frequency of variable number tandem repeats (VNTR)-thymidylate synthase (TS) and its relationship with the disease evolution in colon cancer patients.We selected 24 paraffin-embedded colon cancer tissue samples fro
Autor:
Jose Luis Gonzalez Vela, Jorge Martín Sánchez Guillén, David Hernández Barajas, Sergio Arnoldo Treviño Aguirre, Eloy Cárdenas Estrada, William Orlando Brito Villanueva, Juan Francisco Gonzalez Guerrero
Publikováno v:
Clinical and Translational Oncology. 7:441-446
Objectivo Evaluar la actividad y toxicidad de fluoruracilo en infusion continua y vinorelbina en segunda o tercera linea de tratamiento del cancer de mama metastasico (CMM).
Autor:
Joel Mario Salazar Cavazos, Joan Albanell Mestres, William Orlando Brito Villanueva, José M Baselga Torres, Juan Francisco Gonzalez Guerrero
Publikováno v:
Revista de Oncología. 3:172-182
HER2 is a 185 kDa transmembrane receptor with tyrosine kinase activity encoded by the HER2/neu gene. HER2 is overexpressed in 25%–30% of breast cancer and confers an agressive clinic course. Trastuzumab (Herceptin) is a monoclonal antibody directed